1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction for all-cause mortality and myocardial infarction. 2. ...
1. Among US cancer survivors, metformin was associated with a lower risk of cardiometabolic diseases, all-cause mortality, and cardiometabolic mortality. ...
1. In this retrospective cohort study, individuals with diabetes treated with metformin had a significantly lower risk of developing osteoarthritis ...
1. In a systematic review and meta-analysis of observational studies on patients with diabetes, metformin use was associated with a ...
1. For sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP1) receptor agonists to be used as first-line agents for type ...
1. Compared to sitagliptin and glimepiride, glargine and liraglutide were more effective in achieving target glycated hemoglobin levels in patients ...
![Type I diabetes not associated with early menopause [OVADIA study]](https://www.2minutemedicine.com/wp-content/uploads/2014/12/diabetes1_edited-350x250.jpg)
1. No significant differences in vascular complications of diabetes were seen in patients using metformin and adjunctive glargine, liraglutide, glimepiride, ...
1. Metformin, ivermectin, and fluvoxamine do not prevent hypoxemia, emergency department visits, hospitalization, or death in coronavirus disease 2019 (COVID-19) ...
Click to read this study in JAMA.
1. In patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT-2i) use was associated with reduced risk of composite ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
